Cargando…

Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient

Detalles Bibliográficos
Autores principales:	Han, Yanyan, Long, Jianting, Ye, Sheng, Tao, Ran, Wu, Dongyun, Li, Jin, Zhou, Xiangjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652562/ http://dx.doi.org/10.1186/2051-1426-3-S2-P385

Ejemplares similares

Cancer immunotherapy with multiple tumor antigen activated autologous T cells in patients with HBV related hepatocellular carcinoma
por: Han, Yanyan, et al.
Publicado: (2014)

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013)

Single-step nanoparticle antigen presentation system for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy
por: Molli, Poonam, et al.
Publicado: (2013)

P59. Depleting the suppressors for the benefit of immunotherapy against cervical cancer
por: Draghiciu, O, et al.
Publicado: (2014)

Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy
por: Perica, Karlo, et al.
Publicado: (2014)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
por: Kelderman, Sander, et al.
Publicado: (2013)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy
por: Agrawal, Shruti, et al.
Publicado: (2015)

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014)

Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
por: Zloza, Andrew, et al.
Publicado: (2013)

Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
por: Priceman, Saul, et al.
Publicado: (2015)

Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
por: Han, Yanyan, et al.
Publicado: (2017)

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
por: Heeren, Marijne, et al.
Publicado: (2014)

Seroprevalence of Hepatitis B-surface antigen among selected group of population
por: Karim, Rezaul
Publicado: (2010)

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014)

Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer
por: Cohen, Ezra EW, et al.
Publicado: (2015)

Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
por: Chen, Yu, et al.
Publicado: (2015)

Cervical dysplasia in postmenopausal patients infected by HIV
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
por: Rushworth, David, et al.
Publicado: (2013)

Poster 2016: The effect and value of sublingual immunotherapy: a patient survey
por: Morris, Mary S, et al.
Publicado: (2014)

Food hypersensitivity in patients treated with specific allergen immunotherapy (SIT) for aeroallergens
por: Gocki, J, et al.
Publicado: (2013)

Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients
por: Wyrzykowska, Nina, et al.
Publicado: (2015)

Differential diagnosis of reactive arthritis in a patient with intravesical BCG immunotherapy
por: Aguridă, Aida Roxana, et al.
Publicado: (2014)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
por: Park, Anthony K, et al.
Publicado: (2015)

Antigen-specific T cells conditioned with MDSC display a surprising increased anti-tumor activity after adoptive T cell-based immunotherapy
por: Raber, Patrick, et al.
Publicado: (2015)

High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
por: Ghamande, Sharad, et al.
Publicado: (2015)

Study of treatment outcome of patients of tuberculous cervical lymphedenopathy
por: Mathew, Nisha, et al.
Publicado: (2014)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
por: Skarzynski, Martin, et al.
Publicado: (2015)

House dust mite-specific immunotherapy and tropomyosin sensitizations: harm or benefit for patients?
por: Pevec, B, et al.
Publicado: (2013)

Does IgE-mediated mast cell activation reduce oral tolerance to food antigens?
por: Tunis, M, et al.
Publicado: (2010)

Tumor hypoxia drives immune suppression and immunotherapy resistance
por: Ai, Midan, et al.
Publicado: (2015)

Identification of new manioc allergens and successful oral immunotherapy in a Brazilian allergic patient
por: Santos, KS, et al.
Publicado: (2013)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aodgts33au0ke9dj5cht339nog